Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AER Bill Will Provide Documented History Of Supplement Safety – Industry

This article was originally published in The Tan Sheet

Executive Summary

Supplement trade associations expect the recently introduced adverse event reporting legislation for dietary supplements and OTC drugs to have the greatest effect on the supplement industry's reputation over time by developing an official record of safety
Advertisement

Related Content

FDA Needs To Track Actions Built On Supplement AERs – GAO Report
FDA Needs To Track Actions Built On Supplement AERs – GAO Report
Harkin Exit Intensifies Industry Need To Bolster Supplement Caucus
Senate Vote On Adverse Event Reporting Bill Expected By October
Senate Vote On Adverse Event Reporting Bill Expected By October
CFSAN Priorities: Industry & Consumer Groups Weigh In On NDIs And More
CFSAN Priorities: Industry & Consumer Groups Weigh In On NDIs And More
Senate Vote On AER Bill Around The Corner; NUFA Still Salvageable – Hatch
Bipartisan AER Bill Requires Reporting For All OTC Drugs, Supplements
Bipartisan AER Bill Requires Reporting For All OTC Drugs, Supplements

Topics

Advertisement
UsernamePublicRestriction

Register

PS099550

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel